EXHIBIT 23.1

                         INDEPENDENT AUDITORS' CONSENT


The Board of Directors
Atlantic Pharmaceuticals, Inc.

We  consent  to the use of our  report  dated  March  6,  1996  relating  to the
consolidated balance sheets of Atlantic  Pharmaceuticals,  Inc. and subsidiaries
(a  development  stage company) as of December 31, 1995 and 1994 and the related
consolidated statements of operations,  stockholders' deficit and cash flows for
each of the two years ended December 31, 1995 and 1994, for the period from July
13, 1993 (inception) to December 31, 1993, and for the period from July 13, 1993
(inception)  to December 31,  1995,  incorporated  herein by reference  from the
Company's  annual  report on Form 10-KSB for the fiscal year ended  December 31,
1995.

Our report dated March 6, 1996  contains an  explanatory  paragraph  that states
that the Company has suffered  recurring  losses from operations and has limited
capital resources,  which raises substantial doubt about its ability to continue
as a going concern.  The  consolidated  financial  statements do not include any
adjustments that might result from the outcome of that uncertainty.



                                        /s/ KPMG Peat Marwick LLP


Chicago, Illinois
November 5, 1996